Education
About Us
Working with TipRanks
Follow Us
ProstaLund AB (SE:PLUN)
:PLUN
PLUN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.00 - kr26.76
Previous CloseN/A
Volume452.00
Average Volume (3M)29.95K
Market Cap
kr3.61M
Enterprise ValueN/A
Total Cash (Recent Filing)kr7.82M
Total Debt (Recent Filing)kr933.00K
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
May 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.04
Shares Outstanding3,624,052
10 Day Avg. Volume84,679
30 Day Avg. Volume29,947
Financial Highlights & Ratios
PEG Ratio6.09
Price to Book (P/B)10.41
Price to Sales (P/S)0.00
P/FCF Ratio-0.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PLUN FAQ
What was ProstaLund AB’s price range in the past 12 months?
ProstaLund AB lowest stock price was kr0.99 and its highest was kr26.75 in the past 12 months.
What is ProstaLund AB’s market cap?
ProstaLund AB’s market cap is kr3.61M.
When is ProstaLund AB’s upcoming earnings report date?
ProstaLund AB’s upcoming earnings report date is May 30, 2025 which is in 5 days.
How were ProstaLund AB’s earnings last quarter?
ProstaLund AB released its earnings results on Feb 20, 2025. The company reported -kr2.43 earnings per share for the quarter, missing the consensus estimate of N/A by -kr2.43.
Is ProstaLund AB overvalued?
According to Wall Street analysts ProstaLund AB’s price is currently Overvalued.
Does ProstaLund AB pay dividends?
ProstaLund AB does not currently pay dividends.
What is ProstaLund AB’s EPS estimate?
ProstaLund AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProstaLund AB have?
ProstaLund AB has 3,624,052 shares outstanding.
What happened to ProstaLund AB’s price movement after its last earnings report?
ProstaLund AB reported an EPS of -kr2.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -19.663%.
Which hedge fund is a major shareholder of ProstaLund AB?
Currently, no hedge funds are holding shares in SE:PLUN
Company Description
ProstaLund AB
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Technical Analysis
Scandinavian ChemoTech AB Class B
―
LIDDS AB
―
Prostatype Genomics AB
―
Active Biotech AB
―
Bio-Works Technologies AB
―